Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Inv. presentation
Quarterly results
Carlyle Group Inc. (CG) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 SC 13D/A Carlyle Group Inc. reports a 10% stake in Soleno Therapeutics, Inc.
08/18/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/18/2023 SC 13D/A Carlyle Group Inc. reports a 12.3% stake in Soleno Therapeutics, Inc.
08/04/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 SC 13D/A Carlyle Group Inc. reports a 4.2% stake in Vera Therapeutics, Inc.
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
07/17/2023 SC 13D/A Carlyle Group Inc. reports a 8.1% stake in Carlyle Credit Income Fund
07/05/2023 SC 13D/A Carlyle Group Inc. reports a 5.5% stake in Vera Therapeutics, Inc.
06/16/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
06/01/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF",
"THE CARLYLE GROUP INC. AMENDED AND RESTATED 2012 EQUITY INCENTIVE PLAN"
05/10/2023 SC 13D/A Carlyle Group Inc. has filed a Schedule 13D for Soleno Therapeutics, Inc.
05/09/2023 SC 13D/A Carlyle Group Inc. reports a 8.2% stake in Reneo Pharmaceuticals, Inc.
05/05/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 8-K Quarterly results
04/13/2023 SC 13D/A Carlyle Group Inc. reports a 6.7% stake in Vera Therapeutics, Inc.
04/13/2023 SC 13D/A Carlyle Group Inc. reports a 3.4% stake in Exicure, Inc.
03/28/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
03/22/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
03/22/2023 10-K/A Annual Report for the period ended December 31, 2022 [amend]
03/09/2023 SC 13G Carlyle Group Inc. reports a 6.7% stake in Phathom Pharmaceuticals, Inc.
02/27/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Peter Clare to Retire from Carlyle and as a Member of the Board of Directors after 31 years at the Firm Sandra Horbach and Brian Bernasek to Become Co-Heads of Americas Corporate Private Equity"
02/23/2023 SC 13D/A Carlyle Group Inc. reports a 9.2% stake in Spruce Biosciences, Inc.
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/10/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy